Rose Jung
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 10
- Co-authors
- Robert MacLarenDouglas N. FishMarilee D. ObritschTyree H. KiserSusan L. PendlandChad R. MessickSteven J. MartinJerry Nesamony
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (6 papers)Annals of Pharmacotherapy (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Diagnostic Microbiology and Infectious Disease (3 papers)Critical Care Medicine (2 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Rose Jung
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Molecular Medicine 424
- Applied Microbiology and Biotechnology 151
- Critical Care and Intensive Care Medicine 126
- Pharmaceutical Science 88
- Endocrinology 68
Countries citing papers authored by Rose Jung
This map shows the geographic impact of Rose Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Jung more than expected).
Fields of papers citing papers by Rose Jung
This network shows the impact of papers produced by Rose Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Jung. The network helps show where Rose Jung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rose Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2018 | 28 | |
| 3 | 2014 | 31 | |
| 4 | 2014 | 11 | |
| 5 | 2013 | 21 | |
| 6 | 2013 | 13 | |
| 7 | 2013 | 28 | |
| 8 | 2010 | 30 | |
| 9 | 2006 | 15 | |
| 10 | 2005 | 279 | |
| 11 | 2005 | 55 | |
| 12 | 2005 | 38 | |
| 13 | 2004 | 17 | |
| 14 | 2004 | 24 | |
| 15 | 2003 | 2 | |
| 16 | 2002 | 5 | |
| 17 | 2002 | 23 | |
| 18 | 2002 | 16 | |
| 19 | 2001 | 22 | |
| 20 | 1998 | 44 |
About Rose Jung
Rose Jung is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Pharmaceutical Science and Leadership and Management, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Nosocomial Infections in ICU (5 papers), Respiratory Support and Mechanisms (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Electrolyte and hormonal disorders (3 papers). The work is most often cited by research in Molecular Medicine (424 citations), Applied Microbiology and Biotechnology (151 citations), Critical Care and Intensive Care Medicine (126 citations), Pharmaceutical Science (88 citations) and Endocrinology (68 citations). Rose Jung has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Robert MacLaren, Douglas N. Fish, Marilee D. Obritsch, Tyree H. Kiser, Susan L. Pendland, Chad R. Messick, Steven J. Martin, Jerry Nesamony, Sai H. S. Boddu and Diane M. Cappelletty. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy, Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.